Talimogene Laherparepvec and Radiation Therapy in Treating Patients With Newly Diagnosed Soft Tissue Sarcoma That Can Be Removed by Surgery

Clinical trial NCT02923778 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02923778
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Leiomyosarcoma Liposarcoma Sarcoma G2 Sarcoma G3 Soft Tissue Sarcoma Soft Tissue Sarcoma of the Trunk and Extremities Stage I Soft Tissue Sarcoma AJCC v7 Stage II Soft Tissue Sarcoma AJCC v7 Undifferentiated Pleomorphic Sarcoma

Start date: 2019-12-31
Primary completion: 2026-12-29
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.